Difference between revisions of "Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5 (Q9889)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Added link to [sliswiki]: Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5, #quickstatements; #temporary_batch_1589988087154)
(‎Created claim: Page(s) (P105): 7044-7044, #quickstatements; #temporary_batch_1590074839150)
 
(6 intermediate revisions by the same user not shown)
Property / First Author string
 +
Cortes JE
Property / First Author string: Cortes JE / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1200/jco.2015.33.15_suppl.7044 / rank
 +
Normal rank
Property / Publication Date
 +
2015
Timestamp+2015-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2015 / rank
 +
Normal rank
Property / Published In Name String
 +
J. Clin. Oncol.
Property / Published In Name String: J. Clin. Oncol. / rank
 +
Normal rank
Property / Volume
 +
33
Property / Volume: 33 / rank
 +
Normal rank
Property / title
 +
Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (English)
Property / title: Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (English) / rank
 +
Normal rank
Property / Page(s)
 +
7044-7044
Property / Page(s): 7044-7044 / rank
 +
Normal rank

Latest revision as of 15:47, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Cortes JE
    0 references
    2015
    0 references
    J. Clin. Oncol.
    0 references
    33
    0 references
    Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (English)
    0 references
    7044-7044
    0 references